Top Markets
Coin of the day
LadRx Corporation LadRx Corporation

LadRx Corporation

LADX
Classifica tra le azioni #42092
LadRx Corporation, a biopharmaceutical company, engages in research and... LadRx Corporation, a biopharmaceutical company, engages in research and development of chemotherapeutic drugs for solid tumors in the United States. The company offers linker activated drug releases (LADR) technology, a platform consists of an organic backbone that is attached to a chemotoxic agent that targets and delivers the chemotoxic agent to the tumor environment and release within the tumor. Its lead candidates comprising LADRs 7, 8, 9, and 10 with novel derivatives of the auristatin and maytansinoid drug targeting tumors; and aldoxorubicin, which is in phase II clinical development for the treatment of pancreatic cancer. In addition, the company develops albumin companion diagnostic (ACDx) to identify patients with cancer that benefits from treatment with the four LADR lead candidates. The company was formerly known as CytRx Corporation and changed its name to LadRx Corporation in September 2022. The company was incorporated in 1985 and is headquartered in Los Angeles, California.
Prezzo delle azioni
$0.01
Ultima sincronizzazione: 2026-07-20
Capitalizzazione di mercato
$4.95K
Variazione (1 giorno)
0.00%
Variazione (1 anno)
-98.46%
Paese
US
Scambia LadRx Corporation (LADX)

Categoria

Cronologia dei frazionamenti azionari per LadRx Corporation (LADX)
L’azione LadRx Corporation (simbolo: LADX) ha subito un totale di 0 frazionamenti.
L’ultimo frazionamento è avvenuto il Aug 13, 2026.
Una quota di LADX acquistata prima di Aug 13, 2026 equivale oggi a 0 quote di LADX.
Elenco dei frazionamenti azionari
Anno Frazionamento Moltiplicatore Moltiplicatore cumulativo
Non abbastanza dati per le date fornite.
Frazionamenti azionari di aziende simili o concorrenti
Azienda Numero di frazionamenti azionari Moltiplicatore cumulativo Il paese
1 x2
US
0 -
NL
0 -
CH
0 -
BE
0 -
KR